30.09.2023 | Invited Commentary
Commentary: Outcomes of Metaplastic Breast Cancer vs. Triple-Negative Breast Cancer
verfasst von:
Gaurav Agarwal, K. M. M. Vishvak Chanthar
Erschienen in:
World Journal of Surgery
|
Ausgabe 12/2023
Einloggen, um Zugang zu erhalten
Excerpt
Metaplastic breast cancer (MPBC) is a rare and aggressive subtype of breast cancer that poses additional challenges in clinical management. The study by YuPing Tan et al. presents an analysis comparing the outcomes of MPBC and triple-negative breast cancer (TNBC) using a propensity score matching approach, shedding light on the prognosis and unique characteristics of these subtypes [
1]. The rarity of MPBC has long posed challenges in studying its clinical behavior and outcomes. Prior research has established the considerable heterogeneity of MPBC, with variable biological and clinical behavior, and thus the outcomes. …